Soligenix updates medical advisory board for lymphoma drug development

Go back to Soligenix updates medical advisory board for lymphoma drug development
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.40 +0.02 (5.26%)
Previous Close $0.38    52 Week High $4.35 
Open $0.38    52 Week Low $0.44 
Day High $0.42    P/E N/A 
Day Low $0.38    EPS $-0.81 
Volume 989,175